Hot Topics

• The Commission’s Proposal for the Criteria
• Testing Strategy for the Protection of Public Health
• Environmental Hazard and Risk Assessment
• Status Quo on Global Requirements and Challenges

Presenting Institutions and Companies

• Dr Karin M. Nienstedt, European Commission, DG Health and Food Safety
• Dr Peter Korytar, European Commission, DG Environment
• Dr Elise Grignard, European Commission, Joint Research Centre (JRC)
• Peter Smith, European Chemical Industry Council (Cefic)
• Graeme Taylor, European Crop Protection Association (ECPA)
• Prof Dr ZhiChao Dang, National Institute for Public Health and the Environment (RIVM)
• Dr Glenn Lurman, Federal Institute for Risk Assessment (BfR)
• Dr Miriam Jacobs, Public Health England
• Dr Andy Adams, Bayer S.A.S.
• Dr Richard Green, Dow AgroSciences Ltd.
• Dr Gerard Swaen, Maastricht University
• Dr Christopher J. Borgert, Applied Pharmacology and Toxicology, Inc.
• Dr Volker J. Soballa, Evonik Industries AG
• Dr Martina Duft, Dr. Knoell Consult GmbH
• Dr Martina Vosteen, Ramboll Environ Germany GmbH
• Annegaaike Leopold, Calidris Environment B.V.
• Dr Daniel B. Pickford, Syngenta
• Ellen Dhein, Bayer AG
• Dr Erik K. Rushton, LyondellBasell Industries N.V.
• Dr Lennart Weltje, BASF SE
• The EPA's Endocrine Disruptors Screening Program (EDSP)
  Seema Schappelle, Ph.D., Director, Exposure Assessment Coordination and Policy Division, Office of Science Coordination and Policy Office of Chemical Safety and Pollution Prevention, U.S. EPA

Workshop

Gaining Experience with the Performance of Hazard Assessment of Endocrine Active Substances
Annegaaike Leopold, Calidris Environment B.V.
Prof Peter Matthiessen